Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases

BACKGROUND: PD-1 and CTLA-4 inhibitors are associated with several adverse events including a spectrum of immune-related adverse effects (irAEs). Neurologic irAEs are uncommon occurrences with varied presentations. We describe two separate cases of ipilimumab associated meningoencephalomyelitis and...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Christine A., El-Ali, Alex, Rath, Tanya J., Contis, Lydia C., Gorantla, Vikram, Drappatz, Jan, Davar, Diwakar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117978/
https://www.ncbi.nlm.nih.gov/pubmed/30170622
http://dx.doi.org/10.1186/s40425-018-0393-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117978/
https://www.ncbi.nlm.nih.gov/pubmed/30170622
http://dx.doi.org/10.1186/s40425-018-0393-z

Ejemplares similares